Abstract
Recent research efforts have yielded new pharmacologic agents for the treatment of hyperammonemia (glycerol phenylbutyrate), N-acetylglutamate synthetase (NAGS) deficiency (carglumic acid) and have suggested a potential role for nitric oxide (NO) precursors in the treatment of NO-dependent features of argininosuccinate lyase (ASL) deficiency.
Original language | English |
---|---|
Title of host publication | Current Approach to Hyperammonemia |
Publisher | Future Medicine Ltd. |
Pages | 196-208 |
Number of pages | 13 |
ISBN (Electronic) | 9781780844831 |
ISBN (Print) | 9781780844855 |
State | Published - 1 Mar 2015 |